Rare diseases
Investigational molecules
Locations
Study on the Effects of Maridebart Cafraglutide for Adults with Type 2 Diabetes
PolandStudy on Ublituximab for Patients with Relapsing Multiple Sclerosis
PolandEvaluation of Tirzepatide Versus Placebo in Adolescents with Obesity or Overweight and Weight-Related Comorbidities: A Randomized, Double-Blind Clinical Trial
PolandEvaluation of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Type 2 Diabetes Patients with High Cardiovascular Risk
PolandStudy on Ritlecitinib for Adults and Adolescents with Nonsegmental Vitiligo
PolandWeight loss in adults with obesity (with or without type 2 diabetes) using cagrilintide and semaglutide: a study of two dose levels versus semaglutide alone
PolandGedatolisib plus drug combination for HR‑positive, HER2‑negative advanced breast cancer patients whose disease progressed after CDK4/6 inhibitor therapy
PolandJNJ-95597528 for Adults with Moderate to Severe Atopic Dermatitis
PolandStudy of KAI-9531 in Adults With Obesity or Overweight and Weight-Related Health Problems Without Diabetes
PolandTulisokibart in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease
PolandBaricitinib Compared with Adalimumab and Etanercept in Patients with Rheumatoid Arthritis
PolandComparing the efficacy and safety of KAI-9531 and semaglutide in people living with obesity who do not have diabetes
PolandTell us about your condition – we search every trial in Europe and connect you with the right site.
